Pluristem Therapeutics Overview

  • Founded
  • 2003
Founded
  • Status
  • Public
  • Employees
  • 158
Employees
  • Stock Symbol
  • PSTI
Stock Symbol
  • Share Price
  • $9.15
  • (As of Thursday Closing)

Pluristem Therapeutics General Information

Description

Pluristem Therapeutics Inc is a US-based company that acts as a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions. The lead indications are critical limb ischemia, recovery after surgery for femoral neck fracture, and acute radiation syndrome. The company operations are focused on the research, development, clinical trials, and manufacturing of cell therapeutics and related technologies.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • MATAM Advanced Technology Park
  • Building No. 5
  • Haifa 3508409
  • Israel
+972 000-000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pluristem Therapeutics Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$9.15 $9.00 $2.82 - $13.29 $228M 25.5M 877K -$1.80

Pluristem Therapeutics Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2020 30-Jun-2020 FY 2019 30-Jun-2019 FY 2018 30-Jun-2018
EV 207,161 207,161 82,437 101,885
Revenue 23 23 54 50
EBITDA (27,770) (27,770) (33,730) (24,384)
Net Income (29,152) (29,152) (35,307) (26,126)
Total Assets 65,532 65,532 31,310 38,960
Total Debt 1,585 1,585 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Pluristem Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pluristem Therapeutics‘s full profile, request access.

Request a free trial

Pluristem Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Pluristem Therapeutics Inc is a US-based company that acts as a developer of placenta-based cell therapy product candida
Therapeutic Devices
Haifa, Israel
158 As of 2020
000.00
000000000 000.00

00000000

adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mini
000000000000000
Cleveland, OH
00 As of 0000
0000
000000000 0000

000000 0

xercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repreh
0000000000000
Columbia, MD
000 As of 0000
000.00
0000 0000-00-00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pluristem Therapeutics Competitors (23)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Athersys Corporate Backed or Acquired Cleveland, OH 00 0000 000000000 0000
000000 00000000000 Formerly VC-backed Columbia, MD 000 000.00 000000&0 000.00
00000000 Venture Capital-Backed Birkerød, Denmark 0 0000 0000000000 0 0000
00000000 000000000 Formerly VC-backed Beverly Hills, CA 00 000.00 000000000 - 000.00
00000 Corporation Campbell, CA 00 00000 0000000000.
You’re viewing 5 of 23 competitors. Get the full list »

Pluristem Therapeutics Executive Team (8)

Name Title Board Seat Contact Info
Yaky Yanay Chief Executive Officer & Board Member
Chen Franco Chief Financial Officer
Efrat Livne-Hadass Vice President, Human Resources
Liran Shani Vice President of Clinical & Medical Affairs
Lior Raviv Vice President of Operations & Development
You’re viewing 5 of 8 executive team members. Get the full list »

Pluristem Therapeutics Board Members (9)

Name Representing Role Since
00000 0000000 Pluristem Therapeutics Board Member 000 0000
00000 00000 Pluristem Therapeutics Board Member 000 0000
000000 000-00000 Pluristem Therapeutics Board Member 000 0000
0000 0000000 Pluristem Therapeutics Board Member 000 0000
00000 00000 00.0 Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Pluristem Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pluristem Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pluristem Therapeutics‘s full profile, request access.

Request a free trial